Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

您现在的位置是: 首页 > 实验方法 > 细胞技术

细胞技术

VHL and Kidney Cancer

2025-03-13 细胞技术 加入收藏
Kidney cancer affects approximately 30,000 individuals in the United States and

Kidney cancer affects approximately 30,000 individuals in the United States and is responsible for more than 12,000 deaths each year (1 ,2 ). It has been estimated that 3% of adult malignancies are kidney cancers (1 ). Like many cancers, such as breast and colon cancers, kidney cancer occurs in both sporadic and familial forms. The vast majority of kidney cancer—up to 96%—is sporadic or nonhereditary, while 4% is thought to have a hereditary basis (2 ). There are at least four types of familial kidney cancer that have been categorized: renal carcinoma associated with Birt-Hogg-Dube syndrome, hereditary papillary renal carcinoma, hereditary clear cell renal carcinoma, and renal carcinoma associated with the von Hippel-Lindau (VHL) disease (3 ). This chapter will focus on the recent molecular understanding of VHL disease.

文章底部广告位

文章评论

加载中~